查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
遠端患者監護(RPM) 市場：按類型、應用、最終用戶、地區 - 預測到 2028 年
市場調查報告書
商品編碼
1384223

遠端患者監護(RPM) 市場：按類型、應用、最終用戶、地區 - 預測到 2028 年

Remote Patient Monitoring Market / RPM Market by Product, End user & Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 306 Pages | 訂單完成後即時交付

價格
簡介目錄
調查範圍
調查年份 2021-2028
基準年 2022年
預測期 2023-2028
考慮單位 金額（十億美元）
部分 按類型、按應用程式、按最終用戶、按地區
目標區域 北美、歐洲、亞太地區、拉丁美洲、中東/非洲

全球遠端患者監護市場規模預計將從2023年的140億美元增加到2028年的417億美元，2023年至2028年的年複合成長率為20.1%。

老年人口的增加、擴大醫療服務範圍的需求不斷成長、RPM 減輕醫療資源壓力的能力以及慢性病患病率的上升是推動遠端患者監護(RPM) 市場成長的關鍵因素。這是一個因素。然而，社群媒體的非正式使用可能會限制預測期內的市場成長。

按產品分類，軟體和服務領域預計將在預測期內佔據最大佔有率。此細分市場的最大佔有率主要歸功於遠端患者監護的便利性、高效用以及物聯網（IoT）領域的技術創新。

按類型分類，心臟監護設備在 2022 年遠端患者監護(RPM) 市場中佔據最大佔有率。高血壓和心血管疾病盛行率的上升預計將推動該市場的成長。

從應用來看，2022年糖尿病將佔全球市場最大佔有率。這是由於糖尿病的流行和慢性化、持續監測的要求以及技術的進步。

該報告研究了全球遠端患者監護市場，包括按類型、應用程式、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

第1章 簡介

第2章 調查方法

第3章 執行摘要

第4章 重要考察

第5章 市場概況

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 任務
  • 產業趨勢
  • 關稅和法規分析
  • 生態系分析
  • 價值鏈分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 案例研究分析
  • 波特五力分析
  • 重大會議及活動
  • 主要相關人員和採購標準
  • 價格分析
  • 遠端患者監護市場：未滿足需求分析
  • 贖回場景
  • 影響客戶業務的趨勢/干擾

第6章 遠端患者監護市場（按類型）

  • 介紹
  • 軟體和服務
  • 裝置

第7章 遠端患者監護市場（按應用）

  • 介紹
  • 瘤
  • 心血管疾病
  • 糖尿病
  • 睡眠失調
  • 體重管理和健身監測
  • 其他

第8章 遠端患者監護市場（按最終用戶）

  • 介紹
  • 提供者
  • 付款人
  • 病人
  • 其他

第9章 遠端患者監護市場（按地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章 競爭形勢

  • 介紹
  • 主要參與企業的策略
  • 收益佔有率分析
  • 市場佔有率分析
  • 主要企業企業評價矩陣
  • 新創公司/小型企業評估矩陣
  • 競爭格局及趨勢

第11章公司簡介

  • 主要參與企業
    • KONINKLIJKE PHILIPS NV
    • MEDTRONIC PLC
    • OMRON HEALTHCARE, INC.
    • BOSTON SCIENTIFIC CORPORATION
    • GE HEALTHCARE
    • ABBOTT LABORATORIES
    • ORACLE
    • ALTEN CALSOFT LABS（SUBSIDIARY OF ALTEN GROUP）
    • SIEMENS HEALTHINEERS
    • CLEARARCH, INC.
    • BIOBEAT
    • VIVALNK, INC.
    • VITALCONNECT
    • VIVIFY HEALTH, INC.
    • BARDY DIAGNOSTICS（SUBSIDIARY OF BAXTER）
    • BIOTRONIK SE & CO. KG
    • BROOK, INC.
    • BLUE SPARK TECHNOLOGIES, INC.
  • 其他公司
    • WELCH ALLYN（SUBSIDIARY OF HILL-ROM SERVICES, INC.）
    • HEALTHBEATS PTE LTD.
    • ALIVECOR, INC.
    • TYTOCARE LTD.
    • TELADOC HEALTH, INC.
    • IRHYTHM TECHNOLOGIES, INC.
    • DEXCOM, INC.

第12章附錄

簡介目錄
Product Code: HIT 7776

Report Description

Scope of the Report
Years Considered for the Study2021-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD) Billion
SegmentsType, Application, End User, and Region
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and the Middle East & Africa)

The global remote patient monitoring market is projected to reach USD 41.7 billion by 2028 from USD 14.0 billion in 2023, at a CAGR of 20.1% between 2023 and 2028. The increasing elderly population, the growing need to expand healthcare access, the ability of RPM to reduce the burden on medical resources and the rising prevalence of chronic diseases are the main factors driving the growth of the remote patient monitoring (RPM) market. However, informal use of social media could restrain market growth during the forecast period.

"Software and services segment is estimated to account for the largest share of the market during the forecast period"

Based on product, remote patient monitoring is segmented into software & services and devices. The software & services segment is estimated to account for the largest share during the forecast period. The largest share of this segment is mainly due to the convenience, the high utility of remote patient monitoring, and innovations experienced in the IoT (Internet of Things).

"Cardiac monitoring devices segment is estimated to account for the largest share of the market in 2022"

On the basis of type, the devices market is further segmented into neurological monitoring devices, multiparameter monitoring devices , cardiac monitoring devices, respiratory monitoring devices, blood glucose monitoring devices, fetal & neonatal monitoring devices, and other monitoring devices. In 2022, cardiac monitoring devices held the largest share of the remote patient monitoring (RPM) market. The growing prevalence of individuals with hypertension and cardiovascular diseases is estimated to boost the growth of this market.

Diabetes segment accounted for the largest share of the remote patient monitoring market, by application, in 2022

Based on application, the global remote patient monitoring market is broadly segmented into oncology, cardiovascular diseases, diabetes, sleep disorders, weight management and fitness monitoring. The diabetes segment accounted for the largest share of the global market in 2022. This can be attributed to the prevalence and chronic nature of diabetes, continuous monitoring requirements, and technological advancements.

Providers segment accounted for the largest share of the remote patient monitoring market, by end user, in 2022

The global remote patient monitoring (RPM) market is divided into four main end-user segments: providers, payers, patients, and others. The providers segment held the largest share of the global market in 2022. This is because RPM monitoring devices are improving, more chronically ill and elderly patients are using remote monitoring, and providers are offering more RPM services.

"Asia Pacific is projected to register the highest CAGR during the forecast period".

The market in the Asia Pacific region, is projected to register the highest CAGR during the forecast period. This can be attributed to the emerging APAC countries like India and China are attractive markets for remote patient monitoring (RPM) companies, thanks to their growing elderly population, improving healthcare systems, rapid economic development, and rising living standards.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
  • By Designation: C-level (35%), Director-level (25%), and Others (40%)
  • By Region: North America (25%), Europe (15%), Asia Pacific (45%), Latin America (10%), and Middle East Africa (5%)

The key players operating in this market include Oracle (US), Siemens Healthineers AG (Germany), Omron Healthcare (Japan), Boston Scientific Corporation (US), Clear Arch, Inc (US), TytoCare Ltd. (US), Teledoc Health Inc. (US), Vivify Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), Brook Inc. (US), Blue Spark Technology (US), Welch Allyn (US), Health Beats (Singapore),Medtronic (Ireland), GE Healthcare (US), Abbott Laboratories (US), Alten Calsoft Labs (France), Bio-Beat (Israel), VitalConnect (US), VivaLNK Inc. (US), Bardy Diagnsotics, Inc. (US), Biotronik SE & Co. KG (Germany), Alive Cor, Inc. (US), and iRhythm Technologies (US).

Research Coverage

  • The report studies the remote patient monitoring market based on product, application, end user, and region
  • The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth
  • The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders
  • The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total remote patient monitoring market
  • The report forecasts the revenue of market segments with respect to five major regions

Key Benefits of Buying the Report:

The report will help the leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall market and the sub-segments. This report will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the medical exoskeleton market and provides them information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

  • Analysis of key drivers (rise in the geriatric and medically underserved (especially rural) populations; the growing prevalence of chronic conditions; the benefits of telehealth and telemedicine owing to the current shortage of physicians and care personnel due to the pandemic; increasing investments in telehealth and RPM, and rising technological advancements in telecommunications), restraints (inadequate AI workforce and ambiguous regulatory guidelines for medical software), opportunities (role and impact of AI in remote patient monitoring market, high utility of RPM in combating infectious disease and epidemics), challenges (behavioral barriers, healthcare affordability, and the lack of awareness)
  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the remote patient monitoring market. The report analyzes this market by type, application, and end user.
  • Service Enhancement/Innovation: Detailed insights on upcoming trends in the remote patient monitoring Market
  • Market Development: Comprehensive information on the lucrative emerging markets type, application, end user.
  • Market Diversification: Exhaustive information about new devices and software, growing geographies, recent developments, and investments in the remote patient monitoring Market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the remote patient monitoring Market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SEGMENTATION
    • 1.3.1 REGIONAL SEGMENTATION
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 LIMITATIONS
    • 1.5.1 SCOPE-RELATED LIMITATIONS
    • 1.5.2 METHODOLOGY-RELATED LIMITATIONS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
    • FIGURE 3 INSIGHTS FROM INDUSTRY EXPERTS
      • 2.1.2.2 Breakdown of primary sources
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • FIGURE 6 REMOTE PATIENT MONITORING MARKET: ESTIMATION OF MARKET SIZE THROUGH ADOPTION-BASED APPROACH
    • FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2028)
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 9 TOP-DOWN APPROACH
    • TABLE 1 IMPACT ANALYSIS
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 STUDY ASSUMPTIONS
  • 2.5 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT ANALYSIS
  • 2.6 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 11 REMOTE PATIENT MONITORING MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 REMOTE PATIENT MONITORING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 REMOTE PATIENT MONITORING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 GEOGRAPHIC SNAPSHOT OF REMOTE PATIENT MONITORING MARKET

4 PREMIUM INSIGHTS

  • 4.1 REMOTE PATIENT MONITORING MARKET OVERVIEW
    • FIGURE 15 RISING POPULATION AND GROWING FOCUS ON EXPANDING HEALTHCARE TO DRIVE MARKET DURING FORECAST PERIOD
  • 4.2 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE AND COUNTRY (2022)
    • FIGURE 16 SOFTWARE & SERVICES SEGMENT IN CHINA ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
  • 4.3 REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC MIX
    • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.4 REMOTE PATIENT MONITORING MARKET: DEVELOPED VS. EMERGING MARKETS
    • FIGURE 18 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
    • FIGURE 19 REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2 DRIVERS
    • 5.2.1 GROWTH IN POPULATION AND SUBSEQUENT NEED TO EXPAND HEALTHCARE ACCESS
    • 5.2.2 COST BENEFITS OF TELEHEALTH
    • TABLE 3 CHRONIC DISEASES AND COST BURDEN IN US: POTENTIAL SAVINGS
    • 5.2.3 ABILITY TO REDUCE BURDEN ON MEDICAL RESOURCES
    • 5.2.4 ADVANCEMENTS IN TELECOMMUNICATION
    • 5.2.5 RISING INVESTMENTS IN TELEHEALTH SOLUTIONS
  • 5.3 RESTRAINTS
    • 5.3.1 VARIABLE REGULATORY STANDARDS ACROSS REGIONAL MARKETS
    • TABLE 4 US: STATE-WISE REGULATORY REQUIREMENTS FOR TELEHEALTH
    • 5.3.2 HEALTHCARE FRAUD
    • 5.3.3 INFORMAL USAGE OF SOCIAL MEDIA FOR HEALTHCARE PRACTICES
  • 5.4 OPPORTUNITIES
    • 5.4.1 IMPACT OF AI ON REMOTE PATIENT MONITORING
    • 5.4.2 HIGH UTILIZATION IN INFECTIOUS DISEASE MONITORING
  • 5.5 CHALLENGES
    • 5.5.1 BEHAVIORAL BARRIERS AND HEALTHCARE AFFORDABILITY
    • 5.5.2 DATA ACCESSIBILITY ISSUES
  • 5.6 INDUSTRY TRENDS
    • 5.6.1 GRADUAL SHIFT TO VALUE-BASED AND PATIENT-CENTRIC CARE
    • 5.6.2 INNOVATIONS IN WEARABLE MEDICAL TECHNOLOGY
  • 5.7 TARIFF AND REGULATORY ANALYSIS
    • 5.7.1 TARIFF FOR REMOTE PATIENT MONITORING DEVICES
    • 5.7.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.7.3 NORTH AMERICA
      • 5.7.3.1 US
    • TABLE 6 US: CLASSIFICATION OF MEDICAL EQUIPMENT
    • TABLE 7 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • 5.7.3.2 Canada
    • TABLE 8 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • 5.7.3.3 Europe
    • TABLE 9 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • 5.7.3.4 Asia Pacific
        • 5.7.3.4.1 Japan
    • TABLE 10 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
        • 5.7.3.4.2 China
    • TABLE 11 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
        • 5.7.3.4.3 India
  • 5.8 ECOSYSTEM ANALYSIS
    • FIGURE 20 REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS
  • 5.9 VALUE CHAIN ANALYSIS
    • FIGURE 21 REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS
  • 5.10 TECHNOLOGY ANALYSIS
    • 5.10.1 REMOTE PATIENT MONITORING MARKET: DIGITAL TECHNOLOGY ENABLERS, BENEFITS, AND EXAMPLES
  • 5.11 PATENT ANALYSIS
    • 5.11.1 PATENT PUBLICATION TRENDS
    • FIGURE 22 PATENT PUBLICATION TRENDS: JANUARY 2011-SEPTEMBER 2023
    • 5.11.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR REMOTE PATIENT MONITORING PATENTS (2011-2023)
    • TABLE 12 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING PATENTS
    • 5.11.3 REMOTE PATIENT MONITORING MARKET: TOP APPLICANTS
    • FIGURE 23 TOP APPLICANTS FOR REMOTE PATIENT MONITORING PATENTS (2011-2023)
    • 5.11.4 REMOTE PATIENT MONITORING MARKET: LIST OF PATENTS/PATENT APPLICATIONS
  • 5.12 TRADE ANALYSIS
    • 5.12.1 TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES
    • FIGURE 24 IMPORT OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2022 (USD THOUSAND)
    • FIGURE 25 EXPORTS OF PRODUCTS UNDER HSN CODE: 90189099, BY COUNTRY, 2022 (USD THOUSAND)
  • 5.13 CASE STUDY ANALYSIS
    • TABLE 13 CASE STUDY 1: INTEGRATION OF GARMIN WEARABLE DEVICE DATA INTO MEDTRONIC CARE MANAGEMENT SERVICES (MCMS) RPM PLATFORM
    • TABLE 14 CASE STUDY 2: MOTION-SENSOR TECHNOLOGY FOR EARLY DETECTION OF CVD
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 15 REMOTE PATIENT MONITORING MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 THREAT OF NEW ENTRANTS
    • 5.14.2 THREAT OF SUBSTITUTES
    • 5.14.3 BARGAINING POWER OF MANUFACTURERS
    • 5.14.4 BARGAINING POWER OF BUYERS
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY CONFERENCES AND EVENTS
    • 5.15.1 LIST OF KEY CONFERENCES AND EVENTS (2023-2024)
  • 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING
    • TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY TYPE
    • 5.16.2 BUYING CRITERIA
    • FIGURE 26 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING, BY TYPE
    • TABLE 18 KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING
  • 5.17 PRICING ANALYSIS
    • TABLE 19 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY PLAYERS (2022)
    • TABLE 20 AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES, BY KEY DEVICES (2022)
    • TABLE 21 INDICATIVE PRICING ANALYSIS OF REMOTE PATIENT MONITORING DEVICES, BY REGION, 2021 (USD)
  • 5.18 REMOTE PATIENT MONITORING MARKET: UNMET NEEDS ANALYSIS
    • TABLE 22 UNMET NEEDS IN REMOTE PATIENT MONITORING MARKET
    • 5.18.1 REMOTE PATIENT MONITORING MARKET: END-USER EXPECTATIONS
    • TABLE 23 END-USER EXPECTATIONS IN REMOTE PATIENT MONITORING MARKET
  • 5.19 REIMBURSEMENT SCENARIO
    • TABLE 24 CPT CODES AND REIMBURSEMENT ANALYSIS OF US RPM MARKET
  • 5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • 5.20.1 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET

6 REMOTE PATIENT MONITORING MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 25 REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 6.2 SOFTWARE & SERVICES
    • 6.2.1 AVAILABILITY OF REIMBURSEMENTS FOR RPM SERVICES TO PROPEL MARKET
    • TABLE 26 REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 27 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 28 EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 29 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 30 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 6.3 DEVICES
    • TABLE 31 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 32 REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 33 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 34 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 35 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 36 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.1 CARDIAC MONITORING DEVICES
    • TABLE 37 REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 38 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 39 EUROPE: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 40 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 41 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 42 REMOTE PATIENT MONITORING MARKET FOR CARDIAC MONITORING DEVICES, BY TYPE, 2021-2028 (USD MILLION)
      • 6.3.1.1 BLOOD PRESSURE MONITORING DEVICES
        • 6.3.1.1.1 Growing preference for wearable smartphone-connected devices to boost demand
    • TABLE 43 REMOTE PATIENT MONITORING MARKET FOR BLOOD PRESSURE MONITORING DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.2 NEUROLOGICAL MONITORING DEVICES
      • 6.3.2.1 Rising cases of epilepsy and Alzheimer's to support market growth
    • TABLE 44 REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 45 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 EUROPE: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 48 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR NEUROLOGICAL MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.3 RESPIRATORY MONITORING DEVICES
      • 6.3.3.1 Growing adoption of pulse oximeters to drive market
    • TABLE 49 REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 50 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 51 EUROPE: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 52 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 53 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.4 MULTIPARAMETER MONITORING DEVICES
      • 6.3.4.1 Ability to measure multi-physiological and biochemical ranges to boost demand
    • TABLE 54 REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 55 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 56 EUROPE: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 57 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 58 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR MULTIPARAMETER MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.5 BLOOD GLUCOSE MONITORING DEVICES
      • 6.3.5.1 High incidence of diabetes to drive market
    • TABLE 59 REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 60 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 61 EUROPE: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 62 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 63 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR BLOOD GLUCOSE MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.6 FETAL & NEONATAL MONITORING DEVICES
      • 6.3.6.1 Rising number of preterm births to propel market for RPM devices
    • TABLE 64 REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 65 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 66 EUROPE: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 67 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 68 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR FETAL & NEONATAL MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.7 WEIGHT MONITORING DEVICES
      • 6.3.7.1 Rising obesity levels to fuel uptake
    • TABLE 69 REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 70 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 71 EUROPE: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 72 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 73 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • 6.3.8 OTHER MONITORING DEVICES
    • TABLE 74 REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 75 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 76 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 77 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 78 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER MONITORING DEVICES, BY COUNTRY, 2021-2028 (USD MILLION)

7 REMOTE PATIENT MONITORING MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 79 REMOTE PATIENT MONITORING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 7.2 ONCOLOGY
    • 7.2.1 RISING INCIDENCE OF CANCER TO PROPEL MARKET
    • TABLE 80 REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 81 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 82 EUROPE: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 83 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 84 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.3 CARDIOVASCULAR DISEASES
    • 7.3.1 HIGH INCIDENCE OF CVD TO SUPPORT MARKET GROWTH
    • TABLE 85 REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 86 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 87 EUROPE: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 89 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.4 DIABETES
    • 7.4.1 TECHNOLOGICAL ADVANCEMENTS IN WEARABLE MONITORS TO BOOST DEMAND
    • TABLE 90 REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 91 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 EUROPE: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 94 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.5 SLEEP DISORDERS
    • 7.5.1 WIDE UTILIZATION IN SLEEP APNEA MANAGEMENT TO PROPEL MARKET
    • TABLE 95 REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 96 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 97 EUROPE REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 98 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 99 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.6 WEIGHT MANAGEMENT AND FITNESS MONITORING
    • 7.6.1 CHRONIC DISEASE MANAGEMENT TO SUPPORT MARKET GROWTH
    • TABLE 100 REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 101 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 102 EUROPE: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 103 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT & FITNESS MONITORING, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 104 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR WEIGHT MANAGEMENT AND FITNESS MONITORING, BY COUNTRY, 2021-2028 (USD MILLION)
  • 7.7 OTHER APPLICATIONS
    • TABLE 105 REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 106 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 107 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 108 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 109 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)

8 REMOTE PATIENT MONITORING MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 110 REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 8.2 PROVIDERS
    • TABLE 111 REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 112 REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 113 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 114 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 115 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 116 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.1 HOSPITALS AND CLINICS
      • 8.2.1.1 High incidence of infectious diseases to boost demand
    • TABLE 117 REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 118 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 119 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 121 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.2 HOME CARE SETTINGS AND LONG-TERM CARE CENTERS
      • 8.2.2.1 Advancements in wearable health technology to support market growth
    • TABLE 122 REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 123 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 124 EUROPE: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 125 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 126 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HOME CARE SETTINGS AND LONG-TERM CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.3 AMBULATORY CARE CENTERS
      • 8.2.3.1 Gradual shift to outpatient settings to propel market
    • TABLE 127 REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 128 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 129 EUROPE: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 130 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 131 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • 8.2.4 OTHER PROVIDERS
    • TABLE 132 REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 133 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 134 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 135 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 136 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.3 PAYERS
    • 8.3.1 INCREASING REIMBURSEMENTS FOR RPM SOLUTIONS TO PROPEL MARKET
    • TABLE 137 REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 138 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 139 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 140 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 141 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PAYERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.4 PATIENTS
    • 8.4.1 COST-BENEFITS AND CONVENIENCE OFFERED BY RPM TO SUPPORT MARKET
    • TABLE 142 REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 143 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 144 EUROPE: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 145 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 146 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • 8.5 OTHER END USERS
    • TABLE 147 REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 148 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 149 EUROPE: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 150 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 151 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)

9 REMOTE PATIENT MONITORING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 152 REMOTE PATIENT MONITORING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 27 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET SNAPSHOT
    • 9.2.1 NORTH AMERICA: RECESSION IMPACT
    • TABLE 153 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 154 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 NORTH AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 NORTH AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 157 NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 158 NORTH AMERICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.2 US
      • 9.2.2.1 High healthcare expenditure to boost demand for RPM services
    • TABLE 159 US: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 160 US: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 161 US: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 162 US: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 163 US: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.2.3 CANADA
      • 9.2.3.1 Rising incidence of CVD to support market growth
    • TABLE 164 CANADA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 165 CANADA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 166 CANADA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 167 CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 168 CANADA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.3 EUROPE
    • 9.3.1 EUROPE: RECESSION IMPACT
    • TABLE 169 EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 170 EUROPE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 171 EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 172 EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 173 EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 174 EUROPE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.2 GERMANY
      • 9.3.2.1 Rapid digitization of healthcare systems to drive market growth
    • TABLE 175 GERMANY: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 176 GERMANY: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 177 GERMANY: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 178 GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 179 GERMANY: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Shortage of physicians to boost demand for telehealth solutions
    • TABLE 180 UK: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 181 UK: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 182 UK: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 183 UK: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 184 UK: REMOTE PATIENT MONITORING MARKET FOR PROVIDERS, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.4 FRANCE
      • 9.3.4.1 Favorable government initiatives for telehealth to support market growth
    • TABLE 185 FRANCE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 186 FRANCE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 187 FRANCE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 188 FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 189 FRANCE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.5 ITALY
      • 9.3.5.1 Growing focus on improvements in patient care to drive market
    • TABLE 190 ITALY: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 191 ITALY: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 192 ITALY: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 193 ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 194 ITALY: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.6 SPAIN
      • 9.3.6.1 Rising incidence of chronic diseases to support market growth
    • TABLE 195 SPAIN: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 196 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 197 SPAIN: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 198 SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 199 SPAIN: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.3.7 REST OF EUROPE
    • TABLE 200 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 201 REST OF EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 202 REST OF EUROPE: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 203 REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 204 REST OF EUROPE: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 28 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET SNAPSHOT
    • 9.4.1 ASIA PACIFIC: RECESSION IMPACT
    • TABLE 205 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 206 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 207 ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 208 ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 209 ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 210 ASIA PACIFIC: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 High adoption of telemedicine to drive market
    • TABLE 211 CHINA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 212 CHINA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 213 CHINA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 214 CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 215 CHINA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.3 JAPAN
      • 9.4.3.1 Rising geriatric population and universal healthcare coverage to boost demand
    • TABLE 216 JAPAN: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 217 JAPAN: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 218 JAPAN: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 219 JAPAN: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 220 JAPAN: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.4 INDIA
      • 9.4.4.1 Favorable government policies and high density of population in rural areas to propel market
    • TABLE 221 INDIA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 222 INDIA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 223 INDIA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 224 INDIA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 225 INDIA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.4.5 REST OF ASIA PACIFIC
    • TABLE 226 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 227 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 228 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 229 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 230 REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 231 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 232 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 233 LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 234 LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 235 LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 236 LATIN AMERICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.5.2 BRAZIL
      • 9.5.2.1 Rising adoption of telehealth solutions to support market growth
    • TABLE 237 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 238 BRAZIL: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 239 BRAZIL: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 240 BRAZIL: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 241 BRAZIL: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.5.3 MEXICO
      • 9.5.3.1 Improvements in healthcare infrastructure to boost demand
    • TABLE 242 MEXICO: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 243 MEXICO: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 244 MEXICO: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 245 MEXICO: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 246 MEXICO: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 9.5.4 REST OF LATIN AMERICA
    • TABLE 247 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 248 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 249 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 250 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 251 REST OF LATIN AMERICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 GOVERNMENT INITIATIVES FOR INVESTMENTS IN RPM SOLUTIONS TO SUPPORT MARKET GROWTH
    • 9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 252 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 253 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 254 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING DEVICES MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 255 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2021-2028 (USD MILLION)
    • TABLE 256 MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING FOR PROVIDERS MARKET, BY END USER, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES
    • TABLE 257 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS (JANUARY 2020-OCTOBER 2023)
  • 10.3 REVENUE SHARE ANALYSIS
    • FIGURE 29 REVENUE SHARE ANALYSIS OF KEY PLAYERS
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 30 REMOTE PATIENT MONITORING MARKET: RANKING OF KEY COMPANIES (2022)
  • 10.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 31 REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (2022)
    • 10.5.5 COMPANY FOOTPRINT
    • TABLE 258 REMOTE PATIENT MONITORING MARKET: OVERALL COMPANY FOOTPRINT
    • TABLE 259 REMOTE PATIENT MONITORING MARKET: TYPE FOOTPRINT
    • TABLE 260 REMOTE PATIENT MONITORING MARKET: APPLICATION FOOTPRINT
    • TABLE 261 REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT
    • TABLE 262 REMOTE PATIENT MONITORING MARKET: REGIONAL FOOTPRINT
  • 10.6 START-UP/SME EVALUATION MATRIX
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 RESPONSIVE COMPANIES
    • 10.6.3 DYNAMIC COMPANIES
    • 10.6.4 STARTING BLOCKS
    • FIGURE 32 REMOTE PATIENT MONITORING MARKET: START-UP/SME EVALUATION MATRIX (2022)
    • 10.6.5 COMPETITIVE BENCHMARKING
    • TABLE 263 REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY START-UPS/SMES
  • 10.7 COMPETITIVE SCENARIOS AND TRENDS
    • 10.7.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 264 REMOTE PATIENT MONITORING MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020-OCTOBER 2023)
    • 10.7.2 DEALS
    • TABLE 265 REMOTE PATIENT MONITORING MARKET: KEY DEALS (JANUARY 2020-OCTOBER 2023)

11 COMPANY PROFILES

  • (Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)**
  • 11.1 KEY PLAYERS
    • 11.1.1 KONINKLIJKE PHILIPS N.V.
    • TABLE 266 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
    • FIGURE 33 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
    • 11.1.2 MEDTRONIC PLC
    • TABLE 267 MEDTRONIC PLC: BUSINESS OVERVIEW
    • FIGURE 34 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
    • 11.1.3 OMRON HEALTHCARE, INC.
    • TABLE 268 OMRON HEALTHCARE, INC.: BUSINESS OVERVIEW
    • FIGURE 35 OMRON HEALTHCARE, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.4 BOSTON SCIENTIFIC CORPORATION
    • TABLE 269 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 36 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.5 GE HEALTHCARE
    • TABLE 270 GE HEALTHCARE: BUSINESS OVERVIEW
    • FIGURE 37 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
    • 11.1.6 ABBOTT LABORATORIES
    • TABLE 271 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 38 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
    • 11.1.7 ORACLE
    • TABLE 272 ORACLE: BUSINESS OVERVIEW
    • FIGURE 39 ORACLE: COMPANY SNAPSHOT (2022)
    • 11.1.8 ALTEN CALSOFT LABS (SUBSIDIARY OF ALTEN GROUP)
    • TABLE 273 ALTEN GROUP: BUSINESS OVERVIEW
    • FIGURE 40 ALTEN GROUP: COMPANY SNAPSHOT (2022)
    • 11.1.9 SIEMENS HEALTHINEERS
    • TABLE 274 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW
    • FIGURE 41 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2022)
    • 11.1.10 CLEARARCH, INC.
    • TABLE 275 CLEARARCH, INC.: BUSINESS OVERVIEW
    • 11.1.11 BIOBEAT
    • TABLE 276 BIOBEAT: BUSINESS OVERVIEW
    • 11.1.12 VIVALNK, INC.
    • TABLE 277 VIVALNK, INC.: BUSINESS OVERVIEW
    • 11.1.13 VITALCONNECT
    • TABLE 278 VITALCONNECT: BUSINESS OVERVIEW
    • 11.1.14 VIVIFY HEALTH, INC.
    • TABLE 279 VIVIFY HEALTH, INC.: BUSINESS OVERVIEW
    • 11.1.15 BARDY DIAGNOSTICS (SUBSIDIARY OF BAXTER)
    • TABLE 280 BARDY DIAGNOSTICS: BUSINESS OVERVIEW
    • 11.1.16 BIOTRONIK SE & CO. KG
    • TABLE 281 BIOTRONIK SE & CO.KG: BUSINESS OVERVIEW
    • 11.1.17 BROOK, INC.
    • TABLE 282 BROOK, INC.: BUSINESS OVERVIEW
    • 11.1.18 BLUE SPARK TECHNOLOGIES, INC.
    • TABLE 283 BLUE SPARK TECHNOLOGY, INC.: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 WELCH ALLYN (SUBSIDIARY OF HILL-ROM SERVICES, INC.)
    • 11.2.2 HEALTHBEATS PTE LTD.
    • 11.2.3 ALIVECOR, INC.
    • 11.2.4 TYTOCARE LTD.
    • 11.2.5 TELADOC HEALTH, INC.
    • 11.2.6 IRHYTHM TECHNOLOGIES, INC.
    • 11.2.7 DEXCOM, INC.
  • *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)** might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS